|Articles|April 14, 2009

Coast Issued Warning Letter by FDA

To see FDA news on the warning letter the Agency has issued to coast, please click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships

ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA Commissioner

Coast Issued Warning Letter by FDA

Related Content

When the Slack Runs Out: AI and the CRO Operating Model

What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

Where AI Has the Most Immediate Impact in Phase I Execution

Trending on Applied Clinical Trials Online

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships

ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA Commissioner

One Clinical: Working Together to Advance Trial Collaboration

FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical Devices